drugset / Trial / NCT03511326
PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK
NaSingle-groupOpen-labelOther
Summary
Interventional open label prospective and multicentre study conducted in Germany in subjects with thin or non-hyperkeratotic and non-pigmented multiple AKs in one anatomical area on the face (e.g., forehead or cheek or chin), excluding nose eyelids, lips and mucosa or balding scalp, using Luxerm® DL-PDT treatment.
Timeline
- Start
- 2017-06-07
- Primary completion
- 2017-11-28
- Completion
- 2017-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | methyl aminolevulinate | Small molecule | 16 % | — |